Zenas BioPharma recently reported positive Phase 3 INDIGO trial results for obexelimab in immunoglobulin G4-related disease, showing a clinically meaningful reduction in flare risk and success across ...
For Amy Stubbs, 2026 is starting off on the wrong foot. The managing director of British Garden Centres employs 3,500 staff ...
Introduction Artificial Intelligence lives on data. Without data, large language models (LLMs) cannot learn, adapt, or make ...
Artificial intelligence (AI) is no longer limited to tech labs. OpenAI launched ChaGPT in 2022. Since then AI chatbots have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback